by Richard Daverman, PhD
March 31, 2014 -- AstraZeneca will collaborate with Shenzhen University Health Science Center to discover new treatments for chronic kidney disease, focusing on kidney damage caused by diabetes. Scientists from the Nephrology and Urology Center of Shenzhen University will put their academic and clinical skills together with the drug discovery/research expertise of AstraZeneca’s Shanghai Innovation Center researchers. Terms of the relationship were not disclosed. More details....
Stock Symbol: (NYSE: AZN)
Help employers find you! Check out all the jobs and post your resume.
